Sjögren’s Syndrome News

Smoking may have a protective effect against the development of primary Sjögren’s syndrome, according to research presented at the European League Against Rheumatism Annual European Congress of Rheumatology.

Only a small number of patients with rheumatic diseases said fatigue-related communication with a rheumatologist was not important; however, less than half of patients studied were satisfied with actual communication, and more than three-quarters of patients reported that the fatigue-related communication was initiated by the patient, according to survey results presented at the European League Against Rheumatism Annual European Congress of Rheumatology.

It may be possible to detect the early development of Sjögren’s syndrome distinguished from non-Sjögren’s syndrome sicca symptoms through the use of salivary gland ultrasound, according to recently published data.

Patients with primary Sjögren’s syndrome were at a higher risk for depression, anxiety and sleep disorders than healthy individuals, according to the recently published study results.

Secondary Sjögren’s syndrome may be detected in patients with rheumatoid arthritis though ultrasound images of the salivary glands, according to recently published research.

Patients with primary Sjögren’s syndrome were as likely to have comorbidities such as subclinical atherosclerosis and lower bone mineral density as patients with rheumatoid arthritis and more likely to be at risk than healthy individuals, according to recently published study data.

Fatigue was reported by 98% of patients with autoimmune disorders polled, and fatigue that prevented completion of everyday tasks was reported by 68% of the patients, according to a press release from the American Autoimmune Disease Related Diseases Association.

Oral and ocular symptoms among patients with rheumatoid arthritis may be secondary Sjögren's syndrome and should be investigated with salivary biopsy, according to researchers at the Universidade Federal de Pernambuco in Brazil.

Unresolved issues were present in the treatment and diagnosis of early pulmonary hypertension in patients with inflammatory rheumatic diseases, who are at higher risk for pulmonary arterial hypertension, according to researchers at the Hacettepe University Faculty of Medicine in Ankara, Turkey.

The risk of mortality was higher in patients with rheumatic autoimmune diseases at 30 days and 12 months following myocardial infarction, and patients faced lower rates of revascularization, according to recently published research.